SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Solly Pamela A.

(Last) (First) (Middle)
C/O VISTA GOLD CORP.
7961 SHAFFER PARKWAY, SUITE 5

(Street)
LITTLETON CO 80127

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
VISTA GOLD CORP [ VGZ ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
VP, Investor Relations
3. Date of Earliest Transaction (Month/Day/Year)
03/05/2023
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Shares 03/05/2023 M 11,668 A (1) 169,832 D
Common Shares 03/05/2023 M 32,181 A (1) 202,013 D
Common Shares 03/05/2023 M 8,000 A (1) 210,013 D
Common Shares 03/05/2023 F(2) 19,183 D $0.5248 190,830 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (1) 03/05/2023 M 11,668 (3) (3) Common Shares 11,668 $0 0 D
Restricted Stock Units (1) 03/05/2023 M 32,181 (4) (4) Common Shares 32,181 $0 9,486 D
Restricted Stock Units (1) 03/05/2023 D 3,152 (4) (4) Common Shares 3,152 $0 6,334 D
Restricted Stock Units (1) 03/05/2023 M 8,000 (5) (5) Common Shares 8,000 $0 52,000 D
Restricted Stock Units (1) 03/05/2023 A 96,000 (6) (6) Common Shares 96,000 $0 96,000 D
Explanation of Responses:
1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
2. Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs reported in Table II.
3. 124,000 RSUs were granted on March 1, 2020, and vest as follows: 35,000 over a 36-month period (1/3 at 12 months, 1/3 at 24 months, and 1/3 at 36 months), subject to the reporting person's continuing service as an officer of the Issuer; and 52,000 on March 1, 2022, contingent on share price performance criteria for the Issuer's common shares during the 2-year vesting period. The remaining 37,000 RSUs were subject to performance criteria, and vested on March 1, 2021. Settlement of vested RSUs will occur as soon as administratively feasible following the vesting date.
4. 58,500 RSUs were granted on February 23, 2021, and vest as follows: 19,000 over a 36-month period (1/3 at 12 months, 1/3 at 24 months, and 1/3 at 36 months), subject to the reporting person's continuing service as an officer of the Issuer; and 29,000 on February 23, 2023, contingent on share price performance criteria for the Issuer's common shares during the 2-year vesting period. The remaining 10,500 RSUs are subject to performance criteria, and vested on February 23, 2022. Settlement of vested RSUs will occur as soon as administratively feasible following the vesting date
5. The RSUs granted March 2, 2022, vest as follows: 24,000 over a 36-month period (1/3 at 12 months, 1/3 at 24 months, and 1/3 at 36 months), subject to the reporting person's continuing service as an officer of the Issuer; and 36,000 on March 2, 2024, contingent on share price performance criteria for the Issuer's common shares during the 2-year vesting period. Settlement of vested RSUs will occur as soon as administratively feasible following the vesting date
6. The RSUs granted March 5, 2023, vest as follows: 29,000 over a 36-month period (1/3 at 12 months, 1/3 at 24 months, and 1/3 at 36 months) subject to the reporting person's continuing service as an officer of the Issuer; and 67,000 on March 5, 2025, contingent on share price performance criteria for the Issuer's common shares during the 2-year vesting period. Settlement of vested RSUs will occur as soon as administratively feasible following the vesting date.
/s/ Paula J. Shade as attorney-in-fact for Pamela A. Solly 03/07/2023
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.